IRIS UniCatt

Antonaci, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.432
EU - Europa 1.217
AS - Asia 1.166
SA - Sud America 211
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.376
SG - Singapore 618
NL - Olanda 357
CN - Cina 208
IT - Italia 189
BR - Brasile 171
SE - Svezia 158
FR - Francia 156
DE - Germania 107
VN - Vietnam 86
IE - Irlanda 60
GB - Regno Unito 48
JP - Giappone 40
ID - Indonesia 35
IN - India 30
CA - Canada 28
PL - Polonia 25
RU - Federazione Russa 24
HK - Hong Kong 23
FI - Finlandia 21
TR - Turchia 20
BD - Bangladesh 17
MX - Messico 17
IQ - Iraq 16
AR - Argentina 15
KR - Corea 14
ES - Italia 10
IR - Iran 10
RO - Romania 10
AT - Austria 8
BE - Belgio 8
ZA - Sudafrica 8
PA - Panama 7
LT - Lituania 6
PK - Pakistan 6
CH - Svizzera 5
EC - Ecuador 5
IL - Israele 5
JO - Giordania 5
OM - Oman 5
SA - Arabia Saudita 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KZ - Kazakistan 4
UZ - Uzbekistan 4
VE - Venezuela 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
ME - Montenegro 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.057
Salva come PNG Salva come JPEG
Città #
Singapore 369
Amsterdam 348
Chandler 190
San Jose 175
Ashburn 174
New York 83
Rome 49
Beijing 46
Dublin 46
Los Angeles 46
Tokyo 35
Hefei 34
Jakarta 34
Lauterbourg 31
Munich 31
Dallas 26
Ho Chi Minh City 26
Milan 26
Boston 25
Frankfurt am Main 25
Marseille 25
Hong Kong 22
Princeton 21
San Mateo 19
Hanoi 18
Denver 17
Buffalo 16
São Paulo 16
Warsaw 16
Paris 15
Santa Clara 15
Moscow 14
Nuremberg 14
Orem 14
Seoul 14
The Dalles 14
Chicago 13
Montreal 13
Helsinki 12
Atlanta 11
Palermo 11
Ann Arbor 10
Houston 10
Bremen 9
London 9
Baghdad 8
Düsseldorf 8
Kent 8
Portsmouth 8
Shanghai 8
Ankara 7
Brussels 7
Mexico City 7
Wilmington 7
Belo Horizonte 6
Council Bluffs 6
Hyderabad 6
Johannesburg 6
Menlo Park 6
Poplar 6
Seattle 6
Stockholm 6
Amman 5
Brasília 5
Brescia 5
Chennai 5
Dhaka 5
Fairfield 5
Falkenstein 5
Haiphong 5
Kish 5
Lappeenranta 5
Salvador 5
Toronto 5
Washington 5
Wroclaw 5
Ahmedabad 4
Augusta 4
Bexley 4
Charlotte 4
Da Nang 4
Gustavo Adolfo Madero 4
Phoenix 4
Pittsburgh 4
Redwood City 4
Rio de Janeiro 4
Salt Lake City 4
Turku 4
Almaty 3
Ancona 3
Andover 3
Biên Hòa 3
Boardman 3
Brooklyn 3
Changsha 3
City of London 3
Columbus 3
Grottaferrata 3
Hải Dương 3
Jeddah 3
Totale 2.457
Salva come PNG Salva come JPEG
Nome #
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 498
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 155
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 153
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 149
Predominant distal muscle involvement in spinal muscular atrophy 148
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 142
Early treatment of type II SMA slows rate of progression of scoliosis 130
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 130
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients 129
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 126
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 124
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 122
Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy? 121
New therapies for spinal muscular atrophy: where we stand and what is next 116
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 113
Clinical Variability in Spinal Muscular Atrophy Type III. 113
Sleep disorders in spinal muscular atrophy 111
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 111
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 111
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 107
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 105
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study 102
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 102
Development of an academic disease registry for spinal muscular atrophy 102
P.222Long term progression in type II spinal muscular atrophy: a retrospective observational study 101
Long-term progression in type II spinal muscular atrophy: A retrospective observational study 92
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1) 91
Long term follow-up of scoliosis progression in type II SMA patients 90
Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA. Rome, 13 July 2019 90
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 87
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 82
Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study 82
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 75
Totale 4.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 5 0
2021/2022241 14 4 5 44 18 8 6 31 18 16 38 39
2022/2023537 50 78 31 86 29 66 30 50 75 5 20 17
2023/2024383 7 82 12 35 12 80 28 23 1 30 34 39
2024/2025796 12 14 53 41 70 42 46 24 119 86 161 128
2025/20262.109 252 38 110 260 364 439 341 80 100 124 1 0
Totale 4.110